Peptide-Ruthenium Conjugate as an Efficient Photosensitizer for the Inactivation of Multidrug-Resistant Bacteria.
Anti-Bacterial Agents
/ chemical synthesis
Coordination Complexes
/ chemical synthesis
DNA Damage
/ drug effects
DNA, Superhelical
/ drug effects
Drug Resistance, Bacterial
/ drug effects
Drug Resistance, Multiple
/ drug effects
Gram-Negative Bacteria
/ drug effects
Microbial Sensitivity Tests
Photosensitizing Agents
/ chemical synthesis
Proteins
/ chemical synthesis
Ruthenium
/ chemistry
Singlet Oxygen
/ metabolism
Journal
Inorganic chemistry
ISSN: 1520-510X
Titre abrégé: Inorg Chem
Pays: United States
ID NLM: 0366543
Informations de publication
Date de publication:
19 Oct 2020
19 Oct 2020
Historique:
pubmed:
1
10
2020
medline:
18
5
2021
entrez:
30
9
2020
Statut:
ppublish
Résumé
Antimicrobial photodynamic therapy (APDT) has gained increased attention because of its broad spectrum activity and lower likelihood to elicit bacterial resistance. Although many photosensitizers excel at eradicating Gram-positive bacterial infections, they are generally less potent when utilized against Gram-negative bacteria. We hypothesized that conjugating the DNA-targeting, antimicrobial peptide buforin II to a metal-based photosensitizer would result in a potent APDT agent. Herein, we present the synthesis and characterization of a buforin II-[Ru(bpy)
Identifiants
pubmed: 32993282
doi: 10.1021/acs.inorgchem.0c02491
doi:
Substances chimiques
Anti-Bacterial Agents
0
Coordination Complexes
0
DNA, Superhelical
0
Photosensitizing Agents
0
Proteins
0
buforin II
0
Singlet Oxygen
17778-80-2
Ruthenium
7UI0TKC3U5
Types de publication
Journal Article
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM